Skip to main content
. 2007 Aug 20;51(12):4342–4350. doi: 10.1128/AAC.01414-06

TABLE 1.

Classification and distribution of 247 MR-MSSA isolates by spa lineage with IDI-MRSA results, antibiotic resistance patterns, and MLST results

No. of strains spa lineagea spa type
No. of isolates with the following IDI-MRSA assay result:
Antibiotic resistance patternf
Corresponding ST or CC (n)g
PHRIb Ridomc N1d N2e Positive Negative ELF KTELF KE EF Others
1 B ZZ2PNGKBKGOLB t166 1 1 0 1 1 NDh
18 C TJMBMDMGMK t002 11 7 5 6 1 6 4 ST5 (3)
TJJMBMDMGMK t071 2 2 1 1 2 ST125 (1)
TJMBMDMGMKK t214 1 1 1 1 ST146 (1)
TJMBMDMMMK 1 1 1 1 ST5SLVs (2)
TJMGMK t062 1 1 1 1
TM t2379 1 1 1 1 CC5 (7)
TO2MBMDMBMDMGMK t041 1 1 1 1
1 E UJGFGMDMGGM t148 1 1 1 1 ND
1 F I2Z2EGMJH2M t645 1 1 1 1 ST837 (1)
4 G UJFKBPE t127 1 1 1 1 ST1 (2)
UJFK t2279 2 2 2 2
UJFMGJAGJ t796 1 1 1 1 CC1 (2)
3 H A2MBKE 2 1 2 2 ST45 (1)
XKAX2BMBMB t1768 1 1 1 1 CC45 (1)
206 J YHGFMBQBLO t008 151 49 104 47 116 20 2 4 9
YHFGFMBQBLO t051 3 2 3 1 2
YFGH3MBQBLO 1 1 1 1 ST8 (12)
YFMBQBLO t648 1 1 1 1 ST770 (1)
YHGFMBQLO t1617 1 1 1 1 ST836 (1)
YGFMBOBLO 2 1 2 2
YGFMBQBLO t024 12 11 7 5 8 3 1
YHGCMBQBLO t064 1 1 1 1
YHFMBQBLO t121 8 7 7 1 5 2 1
YHGFMBBLO t400 1 1 1 1
YHGFMBLO t622 1 1 1 1 ST247 (2)
YHGFMBOBLO t2054 5 4 2 3 4 1 ST247SLV (1)
YHGFMBQBM t1578 3 3 1 2 3
YHGFMBQBMO t801 2 2 1 1 1 1
YHGFMBQBQBLO t967 1 1 1 1
YHGGBQBLO t574 1 1 1 1
YHHGGFMBQBLO 2 1 1 1 2 CC8 (17)
YHHGFMBQBLO t068 1 1 1 1
YHBLO t1259 1 1 1 1
YMBQBLO t190 1 1 1 1
YHBQLO 1 1 1 1
YC2BQBLO t197 1 1 1 1
YC2FMBQBLO t304 4 3 4 4
ZHGFMBQBLO 1 1 1 1
9 K UKBBGGJAGJ t760 1 1 1 1
TJGBBGGJAGJ t491 1 1 1 1 ST15 (1)
UJGGBGGJAGJ t499 7 6 6 1 1 6
2 P UJGFMB t189 2 2 2 2 ST188 (1)
1 ND ZDMOB t441 1 1 1 1 ND
1 ND I2GJAABB t587 1 1 1 1 ND
Total 168 79 158 28 13 12 36
a

The spa lineage nomenclature has been described previously (2).

b

spa types according to the Public Health Research Institute nomenclature (PHRI, Newark, NJ).

c

spa types were obtained from the Ridom spa server (SpaServer.ridom.de).

d

N1, numbers of isolates of each spa type.

e

N2, numbers of hospitals where isolates of each spa type have been recovered.

f

E, erythromycin; L, lincomycin; K, kanamycin; T, tobramycin; F, fluoroquinolones.

g

Number of isolates of each ST and clonal complex (CC) in the subset of 30 isolates used for ST determination.

h

ND, not determined.